Sign In
Skip navigation links
Home
About Us
Patient & Public
Professionals
News & Events
Research
 
Search Site
Skip Navigation LinksPCN Internet > Research > Trials > Melanoma Trials
Skip navigation links
Trial Graphs
Bladder Trials
Brain Trials
Breast Trials
Complementary Therapy Trials
Colorectal Trials
Genetic Trials
Gynaecological Trials
Haematological Trials
Head & Neck Trials
Lung Trials
Lymphoma Trials
Melanoma Trials
Other Trials
Prostate Trials
Psychosocial Trials
Radiotherapy Trials
Renal Trials
Sarcoma Trials
Testis Trials
Upper GI Trials
 
Ask a Question ...
Find us on Facebook
Follow us on Twitter
Melanoma Trials 

 

Please see below to view the melanoma trials taking place within the Peninsula Cancer Network

 

AVAST-M

Description:

Adjuvant aVAStin Trial in high risk Melanoma - A randomised trial evaluating the VEGF inhibitor, bevacizumab (Avastin�),as adjuvant therapy following resection of AJCC stage IIB (T3bN0M0 & T4aN0M0), IIC (T4bN0M0) and III (TxN1-3M0) cutaneous melanoma

Phase: Open Type: NCRN
Contact Person Location Stage
Royal Devon & Exeter NHS Foundation TrustOpen
South Devon Healthcare NHS TrustIn Set Up

The Melanoma Lifestyle Study

Description:

The Melanoma Lifestyle Study

Phase: Open Type: NCRN
Contact Person Location Stage
Royal Cornwall Hospitals NHS TrustOpen
 
Page last updated: 16/12/2009 11:23

© 2011 Peninsula Cancer Network, West Yarner, Dartington, Devon TQ9 6DX tel 01803 860 660
 
NHS Direct          Macmillan Cancer Support          Health Service Journal          South West Public Health Observatory